Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo F W Soeterik

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Urology|April 8, 2025
Reply by AuthorsGiancarlo Marra, Francesco Barletta, Simone Scuderi, et al.
The Journal of Urology|February 10, 2025
Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter StudyGiancarlo Marra, Francesco Barletta, Simone Scuderi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2025
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancerTessa D Van Bergen, Arthur J A T Braat, Rick Hermsen, et al.
BJU International|April 20, 2026
Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancerAlexandra S Bruins Slot, Vera Sweere, Joris G Heetman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Physics and Imaging in Radiation Oncology|July 15, 2024
Bringing online adaptive radiotherapy to a standard C-arm linacMaureen L Groot Koerkamp, Gijsbert H Bol, Petra S Kroon, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
The Journal of Urology|April 13, 2023
Reply by AuthorsAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Urology|April 8, 2025
Reply by AuthorsGiancarlo Marra, Francesco Barletta, Simone Scuderi, et al.
The Journal of Urology|February 10, 2025
Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter StudyGiancarlo Marra, Francesco Barletta, Simone Scuderi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2025
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancerTessa D Van Bergen, Arthur J A T Braat, Rick Hermsen, et al.
BJU International|April 20, 2026
Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancerAlexandra S Bruins Slot, Vera Sweere, Joris G Heetman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Physics and Imaging in Radiation Oncology|July 15, 2024
Bringing online adaptive radiotherapy to a standard C-arm linacMaureen L Groot Koerkamp, Gijsbert H Bol, Petra S Kroon, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
The Journal of Urology|April 13, 2023
Reply by AuthorsAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.
Pageof 6